Skip to main content

Aamir Malik

Analyst

Equibles does not estimate personal net worth.

About Aamir Malik

Aamir Malik has spoken on 3 earnings calls across 1 company, most recently for Pfizer Inc on November 3, 2026. The companies whose calls Aamir Malik spoke on are classified in the Healthcare sector.

Aamir Malik on recent calls

“I think three things are probably why we're excited. One, I would just remind everybody that our current commercial footprint is anchored in the U.S. alongside Estellus, but Mevro for us is a fully global opportunity in the U.S. and outside the U.S. So that is very significant and exciting.”
Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts ·
“Chris, I think what's exciting on PATCEF is if you think about the data Chris shared, our indicated uses for PADSF and PEMBRO now span the entire continuum, all the way from curative intent MIBC through to metastatic disease, all independent of cisplatin and eligibility.”
Pfizer Inc Q2 FY2026 Earnings Call ·
“Vaccination rates in the U.S., obviously, it's very different for every segment. in COVID with Comirnaty, there was a narrowing of the label. So we did see a shrinking of the market a bit.”
Pfizer Inc Q1 FY2026 Earnings Call ·

Company network

Recent activity